The global market for Maropitant Citrate Injectable Solution was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 405 million by 2031, growing at a CAGR of 6.8% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Maropitant Citrate Injectable Solution competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Maropitant Citrate Injectable Solution is a veterinary prescription medication commonly used in dogs and cats for the prevention and treatment of vomiting caused by various conditions, including motion sickness, gastroenteritis, and chemotherapy-induced nausea. Its active ingredient, maropitant, is a highly selective neurokinin-1 (NK1) receptor antagonist that works by inhibiting the action of substance P鈥攁 key neurotransmitter involved in the vomiting reflex鈥攂oth in the central and peripheral nervous systems. The injectable formulation is typically administered subcutaneously or intravenously, making it ideal for animals unable to take oral medications or in need of rapid symptom control. Known for its rapid onset and long duration of action (up to 24 hours), it is a widely used antiemetic in small animal practice. A leading commercial product is Cerenia庐, manufactured by Zoetis.
North American market for Maropitant Citrate Injectable Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Maropitant Citrate Injectable Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Maropitant Citrate Injectable Solution include Zoetis, Dechra Vet Products, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Maropitant Citrate Injectable Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maropitant Citrate Injectable Solution.
The Maropitant Citrate Injectable Solution market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Maropitant Citrate Injectable Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Maropitant Citrate Injectable Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zoetis
Dechra Vet Products
Segment by Type
10ml Per Bottle
20ml Per Bottle
Segment by Application
Canine
Feline
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Maropitant Citrate Injectable Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Maropitant Citrate Injectable Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Maropitant Citrate Injectable Solution 麻豆原创 Overview
1.1 Product Definition
1.2 Maropitant Citrate Injectable Solution by Type
1.2.1 Global Maropitant Citrate Injectable Solution 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 10ml Per Bottle
1.2.3 20ml Per Bottle
1.3 Maropitant Citrate Injectable Solution by Application
1.3.1 Global Maropitant Citrate Injectable Solution 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Canine
1.3.3 Feline
1.4 Global Maropitant Citrate Injectable Solution 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Maropitant Citrate Injectable Solution Revenue 2020-2031
1.4.2 Global Maropitant Citrate Injectable Solution Sales 2020-2031
1.4.3 Global Maropitant Citrate Injectable Solution 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Maropitant Citrate Injectable Solution 麻豆原创 Competition by Manufacturers
2.1 Global Maropitant Citrate Injectable Solution Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Maropitant Citrate Injectable Solution Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Maropitant Citrate Injectable Solution Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Maropitant Citrate Injectable Solution, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Maropitant Citrate Injectable Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Maropitant Citrate Injectable Solution, Product Type & Application
2.7 Global Key Manufacturers of Maropitant Citrate Injectable Solution, Date of Enter into This Industry
2.8 Global Maropitant Citrate Injectable Solution 麻豆原创 Competitive Situation and Trends
2.8.1 Global Maropitant Citrate Injectable Solution 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Maropitant Citrate Injectable Solution Players 麻豆原创 Share by Revenue
2.8.3 Global Maropitant Citrate Injectable Solution Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Maropitant Citrate Injectable Solution 麻豆原创 Scenario by Region
3.1 Global Maropitant Citrate Injectable Solution 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Maropitant Citrate Injectable Solution Sales by Region: 2020-2031
3.2.1 Global Maropitant Citrate Injectable Solution Sales by Region: 2020-2025
3.2.2 Global Maropitant Citrate Injectable Solution Sales by Region: 2026-2031
3.3 Global Maropitant Citrate Injectable Solution Revenue by Region: 2020-2031
3.3.1 Global Maropitant Citrate Injectable Solution Revenue by Region: 2020-2025
3.3.2 Global Maropitant Citrate Injectable Solution Revenue by Region: 2026-2031
3.4 North America Maropitant Citrate Injectable Solution 麻豆原创 Facts & Figures by Country
3.4.1 North America Maropitant Citrate Injectable Solution 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Maropitant Citrate Injectable Solution Sales by Country (2020-2031)
3.4.3 North America Maropitant Citrate Injectable Solution Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Maropitant Citrate Injectable Solution 麻豆原创 Facts & Figures by Country
3.5.1 Europe Maropitant Citrate Injectable Solution 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Maropitant Citrate Injectable Solution Sales by Country (2020-2031)
3.5.3 Europe Maropitant Citrate Injectable Solution Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Maropitant Citrate Injectable Solution 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Maropitant Citrate Injectable Solution 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Maropitant Citrate Injectable Solution Sales by Region (2020-2031)
3.6.3 Asia Pacific Maropitant Citrate Injectable Solution Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Maropitant Citrate Injectable Solution 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Maropitant Citrate Injectable Solution 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Maropitant Citrate Injectable Solution Sales by Country (2020-2031)
3.7.3 Latin America Maropitant Citrate Injectable Solution Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Maropitant Citrate Injectable Solution 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Maropitant Citrate Injectable Solution 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Maropitant Citrate Injectable Solution Sales by Country (2020-2031)
3.8.3 Middle East and Africa Maropitant Citrate Injectable Solution Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Maropitant Citrate Injectable Solution Sales by Type (2020-2031)
4.1.1 Global Maropitant Citrate Injectable Solution Sales by Type (2020-2025)
4.1.2 Global Maropitant Citrate Injectable Solution Sales by Type (2026-2031)
4.1.3 Global Maropitant Citrate Injectable Solution Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Maropitant Citrate Injectable Solution Revenue by Type (2020-2031)
4.2.1 Global Maropitant Citrate Injectable Solution Revenue by Type (2020-2025)
4.2.2 Global Maropitant Citrate Injectable Solution Revenue by Type (2026-2031)
4.2.3 Global Maropitant Citrate Injectable Solution Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Maropitant Citrate Injectable Solution Price by Type (2020-2031)
5 Segment by Application
5.1 Global Maropitant Citrate Injectable Solution Sales by Application (2020-2031)
5.1.1 Global Maropitant Citrate Injectable Solution Sales by Application (2020-2025)
5.1.2 Global Maropitant Citrate Injectable Solution Sales by Application (2026-2031)
5.1.3 Global Maropitant Citrate Injectable Solution Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Maropitant Citrate Injectable Solution Revenue by Application (2020-2031)
5.2.1 Global Maropitant Citrate Injectable Solution Revenue by Application (2020-2025)
5.2.2 Global Maropitant Citrate Injectable Solution Revenue by Application (2026-2031)
5.2.3 Global Maropitant Citrate Injectable Solution Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Maropitant Citrate Injectable Solution Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Maropitant Citrate Injectable Solution Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Maropitant Citrate Injectable Solution Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Dechra Vet Products
6.2.1 Dechra Vet Products Company Information
6.2.2 Dechra Vet Products Description and Business Overview
6.2.3 Dechra Vet Products Maropitant Citrate Injectable Solution Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Dechra Vet Products Maropitant Citrate Injectable Solution Product Portfolio
6.2.5 Dechra Vet Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Maropitant Citrate Injectable Solution Industry Chain Analysis
7.2 Maropitant Citrate Injectable Solution Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Maropitant Citrate Injectable Solution Production Mode & Process Analysis
7.4 Maropitant Citrate Injectable Solution Sales and 麻豆原创ing
7.4.1 Maropitant Citrate Injectable Solution Sales Channels
7.4.2 Maropitant Citrate Injectable Solution Distributors
7.5 Maropitant Citrate Injectable Solution Customer Analysis
8 Maropitant Citrate Injectable Solution 麻豆原创 Dynamics
8.1 Maropitant Citrate Injectable Solution Industry Trends
8.2 Maropitant Citrate Injectable Solution 麻豆原创 Drivers
8.3 Maropitant Citrate Injectable Solution 麻豆原创 Challenges
8.4 Maropitant Citrate Injectable Solution 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Zoetis
Dechra Vet Products
听
听
*If Applicable.